Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial-MedSci.cn

Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial

Cereno, RE; Mou, B; Baker, S; Chng, N; Arbour, G; Bergman, A; Liu, M; Schellenberg, D; Matthews, Q; Huang, V; Mestrovic, A; Hyde, D; Alexander, A; Carolan, H; Hsu, F; Atrchian, S; Mohamed, I; Lin, A; Berrang, T; Bang, A; Jiang, W; Pai, H; Tyldesley, S; Olson, R